A CHANCE FOR CLEARER SKIN: JOIN OUR ECZEMA TRIAL!
Help us to bring a new treatment option to Atopic Dermatitis (eczema). This study evaluates the formulation, CHD-FA 4% Cream, for its efficacy, safety and tolerability in patients suffering from mild to moderate Atopic Dermatitis. There will be 4 – 5 visits at the UCT Lung Institute, where you will be seen by a doctor and dermatologist.
- Who can Join? Anyone 16 years of age or older with a history of eczema for more than 1 year, with 5 to 20 handprints of eczema covering the body
- How to Join: Contact the UCT Lung Institute to book your screening visit
- How long is this clinical trial? The study duration is 4 – 6 weeks
If you, or someone you know of, is interested, please contact us:
CONTACT DETAILS:
- Tel: 021 406 6889
- Whatsapp: 066 185 1879
- Address: George Street, Mowbray, Cape Town, 7700
- PI: Prof J Peter
This study has been approved by SAHPRA (South African Health Products Regulatory Authority) and UCT FHS HREC: hrecenquiries@uct.ac.za
Download pdf pamphlet here>>>
